LOS ANGELES, CA / ACCESSWIRE / September 29, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GTT Communications, Inc. ("GTT" or "the Company") (NYSE:GTT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 26, 2018 and July 1, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before September 30, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. GTT experienced significant delays in integrating Interoute Communications Holdings S.A.'s ("Interoute") systems and legacy processes into the Company's client management database. Interoute had made selling cloud services a strategic priority, but a considerable percentage of Interoute sales reps were not able to effectively sell GTT's cloud networking services. In fact, Interoute had allowed underperforming sales reps to remain on staff. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about GTT, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561421

Class-action law firm urges CARB investors to learn their shareholder rights against Carbonite in filed lawsuit

SAN FRANCISCO, CA / ACCESSWIRE / September 29, 2019 / Hagens Berman reminds investors in Carbonite, Inc. (NASDAQ:CARB) of tomorrow's September 30, 2019 deadline to move for lead plaintiff in a federal securities class action pending against the Company.

If you invested in Carbonite between February 7, 2019 and July 25, 2019 (the "Class Period") and suffered significant losses (in excess of $50,000) you may qualify to be a lead plaintiff – one who selects and oversees the attorneys prosecuting the case.

If you wish to serve as a lead plaintiff in this class action, you must move the Court no later than September 30, 2019 (the "Lead Plaintiff deadline"). Contact Hagens Berman immediately for more information about the case and being a lead plaintiff:

https://www.hbsslaw.com/investor-fraud/CARB

or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing

CARB@hbsslaw.com.

According to the Complaint, Defendants misled investors about the technological quality of the Company's Server Backup VM Edition and its potential to add "meaningfully" to Carbonite's financial performance for fiscal 2019. In truth, according to the Complaint, the Server Backup VM Edition's functionality was of poor quality and suffered from technological flaws, received poor customer reviews and complaints, and caused disruption within Carbonite's salesforce.

On July 25, 2019, the market learned the truth when Carbonite announced that it was withdrawing the Server Backup VM Edition product from the marketplace and consequently dramatically lowered its financial projections for fiscal 2019 and 2020. That same day, Carbonite's CEO Mohamad S. Ali – the strongest proponent and supporter of Server Backup VM Edition – abruptly stepped down.

On this news, Carbonite stock declined nearly 25%, wiping out over $200 million in market capitalization.

"We're focused on are investors' losses and whether Carbonite misled investors about the quality and functionality of its Server Backup VM Edition product," said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Carbonite should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email CARB@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

SOURCE: Hagens Berman Sobol Shapiro LLP

ReleaseID: 561317

NEW YORK, NY / ACCESSWIRE / September 29, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Abiomed, Inc. (NASDAQGS:ABMD)

Lawsuit on behalf of: investors who purchased January 31, 2019 – July 31, 2019
Lead Plaintiff Deadline : October 7, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/abiomed-inc-loss-form?prid=3749&wire=1

According to the filed complaint, during the class period, Abiomed, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Abiomed's revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company's prior projections and market expectations; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Lawsuit on behalf of: investors who purchased September 6, 2017 – August 19, 2019
Lead Plaintiff Deadline : October 29, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sarepta-therapeutics-inc-loss-form?prid=3749&wire=1

According to the filed complaint, during the class period, Sarepta Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) golodirsen, Sarepta's drug for the treatment of Duchenne muscular dystrophy, posed significant safety risks to patients; (ii) consequently, the New Drug Application package for golodirsen's accelerated approval was unlikely to receive Food and Drug Administration approval; and (iii) as a result, Sarepta's public statements were materially false and misleading at all relevant times.

Tencent Music Entertainment Group (NYSE:TME)

Lawsuit on behalf of: investors who purchased December 12, 2018 – August 26, 2019
Lead Plaintiff Deadline : November 25, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tencent-music-entertainment-group-loss-form?prid=3749&wire=1

According to the filed complaint, during the class period, Tencent Music Entertainment Group made materially false and/or misleading statements and/or failed to disclose that: (1) Tencent Music's exclusive licensing arrangements with major record labels were anticompetitive; (2) consequently, sublicensing such content from Tencent Music was unreasonably expensive, in violation of Chinese antimonopoly laws; (3) these anticompetitive efforts were reasonably likely to lead to regulatory scrutiny; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 561403

NEW YORK, NY / ACCESSWIRE / September 29, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Evolent Health, Inc. (NYSE:EVH)
Investors Affected : March 3, 2017 – May 28, 2019

A class action has commenced on behalf of certain shareholders in Evolent Health, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Evolent's partnership model was not aligned with its partners, as it was designed to parasitically increase its own revenue by extracting enormous administrative and management fees at the expense of its partners such as Passport Health Plan ("Passport"); (2) Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was becoming increasingly unsustainable; (3) Evolent was draining Passport of functions, employees, and money to such an extent that Passport was left on the verge of insolvency; (4) for several months, Passport was conducting a bidding process to sell itself to a financial buyer to prevent liquidation; and (5) as a result of the foregoing, Defendants public statements were materially false and/or misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/evolent-health-inc-loss-submission-form/?id=3754&from=1

Valaris plc (NYSE:VAL)
Investors Affected : April 11, 2019 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Valaris plc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (iii) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/valaris-plc-loss-submission-form/?id=3754&from=1

Ollies Bargain Outlet Holdings, Inc. (NASDAQ:OLLI)
Investors Affected : June 6, 2019 – August 28, 2019

A class action has commenced on behalf of certain shareholders in Ollies Bargain Outlet Holdings, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company suffered a supply chain issue that impacted the initial inventory available at new stores; (2) as a result, the Company lacked sufficient inventory to meet demand at certain store locations; (3) as a result, the Company’s comparable store sales were likely to decrease quarter-over-quarter; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ollies-bargain-outlet-holdings-inc-loss-submission-form/?id=3754&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 561408

NEW YORK, NY / ACCESSWIRE / September 29, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

GTT Communications, Inc. (NYSE:GTT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/gtt-communications-inc-loss-submission-form?prid=3750&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: February 26, 2018 to July 1, 2019

Allegations against GTT include that: (1) following GTT's acquisition of Interoute Communications Holdings S.A., there were delays in migrating Interoute's legacy systems and processes into GTT's client management database system; (2) Interoute had made a strategic priority shift to sell cloud services that was a higher percentage of Interoute's sales in the two years leading up to the acquisition; (3) a material percentage of the Interoute sales representatives were not productive at selling GTT's core cloud networking services; (4) GTT was unable to yield as many Interoute salespeople because Interoute had hired many sales people focused on cloud services and allowed underperforming sales representatives to remain at Interoute; and (5) as a result of the foregoing, Defendants' public statements were materially false and/or misleading and/or lacked a reasonable basis.

Cardinal Health, Inc. (NYSE:CAH)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cardinal-health-inc-loss-submission-form?prid=3750&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: March 2, 2015 to May 2, 2018

Allegations against CAH include that: 1) following Cardinal's acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis's performance were never implemented across Cordis; 2) Cordis's antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; 3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; 4) the Company materially overstated Cordis's inventory balances; 5) Cordis was not "performing well" and its integration was not "on track," "going incredibly well" or "largely on plan"; and 6) to correct Cordis's deficiencies, the Company would have to make substantial investments in Cordis's IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

International Flavors & Fragrances Inc. (NYSE:IFF)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/international-flavors-fragrances-inc-loss-submission-form?prid=3750&wire=1
Lead Plaintiff Deadline: October 11, 2019
Class Period: May 7, 2018 to August 5, 2019

Allegations against IFF include that: (1) Frutarom Industries Ltd. ("Frutarom"), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) senior management at Frutarom were aware of such improper payments; (3) as a result, Frutarom's financial results were materially overstated; (4) as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) the Company had not completed adequate due diligence before acquiring Frutarom; (6) as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 561404

NEW YORK, NY / ACCESSWIRE / September 29, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Textron Inc. (NYSE:TXT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/textron-inc-loss-submission-form?prid=3751&wire=1
Lead Plaintiff Deadline: October 21, 2019
Class Period: January 31, 2018 to October 17, 2018

Allegations against TXT include that: (1) end market sales of Arctic Cat products were slowing, resulting in a massive glut of old Arctic Cat inventory on dealers' floors; (2) in order to clear out this old inventory, the Company provided significant price discounts, which negatively impacted Textron's earnings; and (3) as a result, Textron's positive statements about Arctic Cat's business, operations, and prospects lacked a reasonable basis.

Meredith Corporation (NYSE:MDP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/meredith-corporation-loss-submission-form?prid=3751&wire=1
Lead Plaintiff Deadline: November 5, 2019
Class Period: January 31, 2018 to September 5, 2019

Allegations against MDP include that: (1) the Time, Inc. acquisition was not as profitable as the Company had claimed; (2) the Company would incur additional costs for strategic investments to improve the Time business; (3) as a result, the Company's earnings would be materially and adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Cadence Bancorporation (NYSE:CADE)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cadence-bankcorporation-loss-submission-form?prid=3751&wire=1
Lead Plaintiff Deadline: November 15, 2019
Class Period: July 23, 2018 to July 22, 2019

Allegations against CADE include that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company's loans posed an increased risk of loss; (3) as a result, the Company was reasonably likely to incur significant losses for certain loans; (4) the Company's financial results would suffer a material adverse impact; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 561405

CEDARHURST, NY / ACCESSWIRE / September 29, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

Pluralsight, Inc. (NASDAQGS:PS)

Investors Affected : August 2, 2018 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Pluralsight, Inc. According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering ("SPO") that it was behind schedule onboarding new sales representatives, which was hurting the Company's sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

Shareholders may find more information at https://kclasslaw.com/securities/pluralsight-inc-loss-submission-form/?id=3752&from=1

2U, Inc. (NASDAQGS:TWOU)

Investors Affected : February 26, 2018 – July 30, 2019

A class action has commenced on behalf of certain shareholders in 2U, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) 2U's business model was fundamentally flawed because the Company's costs were growing disproportionately as it grew in size and complexity; (b) 2U could not take advantage of the promised economies of scale because its costs to attract each marginal student were actually increasing, not decreasing, as represented; (c) 2U was facing heightened competitive headwinds as alternative offerings flooded the marketplace and universities developed online courses in-house; (d) 2U's growth rate in student enrollment was decelerating and was poised to decline as the Company reached market saturation; (e) 2U's growth strategy was unsustainable, as the Company faced accelerating costs and had insufficient capital to achieve positive cash flows, improve margins or continue its revenue growth; and (f) as a result of (a)-(e), above, Defendants lacked any reasonable basis to issue 2U's projections and financial forecasts.

Shareholders may find more information at https://kclasslaw.com/securities/2u-inc-loss-submission-form/?id=3752&from=1

CVS Health Corporation (NYSE:CVS)

Investors Affected : on behalf of all former Aetna Inc. shareholders who acquired CVS Health Corporation (CVS) shares in exchange for their Aetna shares in connection with CVS's acquisition of Aetna on November 28, 2018.

A class action has commenced on behalf of certain shareholders in CVS Health Corporation. According to the filed complaint, CVS made false and/or misleading statements in connection with its acquisition of Aetna and/or failed to disclose that: (a) by the end of 2017, CVS's financial condition and expected earnings had deteriorated as a result of rising costs and poor results being experienced in the long-term care ("LTC") unit associated with the 2015 acquisition of Omnicare; (b) in 2017, deteriorating conditions and prospects in CVS 's LTC unit prompted CVS to undertake hasty acquisitions of LTC pharmacies to compensate for the declining LTC business and/or mask the expected LTC goodwill impairment ahead of the planned Acquisition; (c) although negative LTC performance factors prompted CVS and the CVS Individual Defendants to make hasty LTC pharmacy acquisitions in 2017, those same negative factors were being overlooked and ignored for purposes of undertaking, disclosing, and reporting the results of LTC goodwill impairment tests throughout 2017, in violation of GAAP; (d) the LTC goodwill being carried on CVS's books as a result of the Omnicare acquisition was being carried at inflated values that would require billions of dollars in impairment charges that would be charged against earnings; and (e) as a result of the foregoing, CVS's true business metrics and financial prospects were not as the Offering Documents represented.

Shareholders may find more information at https://kclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=3752&from=1

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967

SOURCE: Kuznicki Law PLLC

ReleaseID: 561406

CEDARHURST, NY / ACCESSWIRE / September 29, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

NetApp, Inc. (NASDAQGS:NTAP)

Investors Affected : May 22, 2019 – August 1, 2019

A class action has commenced on behalf of certain shareholders in NetApp, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was unable to close large deals within the quarter and that the deals were pushed out to subsequent quarters or downsized; (2) as a result, the Company's revenue would be materially impacted; (3) as a result, the Company would lower its fiscal 2020 guidance; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/netapp-inc-loss-submission-form/?id=3753&from=1

Farfetch Limited (NYSE:FTCH)

Investors Affected : all persons and entities who purchased or otherwise acquired Farfetch Class A ordinary shares between September 21, 2018, and August 8, 2019, inclusive, including those who purchased or otherwise acquired Farfetch Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with Company's September 21, 2018 initial public offering.

A class action has commenced on behalf of certain shareholders in Farfetch Limited . The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would refuse to reduce merchandise prices to match the rest of the market; (2) this sub-optimal pricing strategy rendered the Company's platform highly susceptible to underpricing by competitors, despite what Defendants touted as a "superior" platform; and (3) as a result, the Company's past and projected Platform Gross Merchandise Value growth rates were foreseeably unsustainable. As a result of the foregoing, Defendants' statements about the Company's business strategy and growth prospects lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/farfetch-loss-submission-form/?id=3753&from=1

Viewray, Inc. (NASDAQ:VRAY)

Investors Affected : March 15, 2019 – August 8, 2019

A class action has commenced on behalf of certain shareholders in Viewray, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) demand for ViewRay systems had declined due in part to changes being made to Medicare reimbursement approaches first announced in November 2019 that could make purchases of new ViewRay systems less profitable for customers; (b) the Company's reported backlog was overstated due to the inclusion of orders with insufficient surety as to permit for their inclusion in reported backlog; and (c) as a result of the foregoing, defendants' positive statements about ViewRay's business metrics and financial prospects during the Class Period were materially false and misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/viewray-inc-loss-submission-form/?id=3753&from=1

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967

SOURCE: Kuznicki Law PLLC

ReleaseID: 561407